We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HTBX market cap is 72.62M. The company's latest EPS is USD -1.6926 and P/E is -0.24.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 9.16M | 189k | 1.76M | 658k | 723k |
Operating Income | -13M | -15.5M | -13.04M | -13.32M | -8.35M |
Net Income | -13.01M | -12.15M | -12.79M | -13.89M | -13.13M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 5.79M | 3.05M | 2.95M | 2.11M | 9.84M |
Operating Income | -17.96M | -20.75M | -24.93M | -34.99M | -45.69M |
Net Income | -15.73M | -20.02M | -26.05M | -35.07M | -43.44M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 120.17M | 104.4M | 91.52M | 80.18M | 69.92M |
Total Liabilities | 37.04M | 31.96M | 31.18M | 33.12M | 36.47M |
Total Equity | 83.13M | 72.44M | 60.34M | 47.07M | 33.45M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 37.76M | 25.96M | 124.2M | 120.96M | 104.4M |
Total Liabilities | 7.52M | 12.8M | 8.7M | 8.93M | 31.96M |
Total Equity | 30.24M | 13.16M | 115.49M | 112.03M | 72.44M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 2.14M | -5.7M | -13.79M | -22M | -30.46M |
Investing | 3.62M | 10.99M | 13.49M | 22.32M | 30.14M |
Financing | -146k | -4.91M | -299k | -2.92M | -2.75M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -21.71M | -12.84M | -22.02M | -38.13M | -5.7M |
Investing | -6.16M | -293k | -95.42M | 9.77M | 10.99M |
Financing | 40.12M | 19k | 119.33M | 25.49M | -4.91M |
Market Cap | 72.62M |
Price to Earnings Ratio | -0.24 |
Price to Sales Ratio | 1.07 |
Price to Cash Ratio | 1.25 |
Price to Book Ratio | 0.15 |
Dividend Yield | - |
Shares Outstanding | 25.66M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.08 (2.77%) |
Company Name | Heat Biologics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://ir.scorpiusbiologics.com/ |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions